BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23046156)

  • 1. Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.
    Zhou J; Rossi JJ
    BioDrugs; 2012 Dec; 26(6):393-400. PubMed ID: 23046156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.
    Zhou J; Rossi J
    J Investig Med; 2014 Oct; 62(7):914-9. PubMed ID: 25118114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.
    Zhou J; Satheesan S; Li H; Weinberg MS; Morris KV; Burnett JC; Rossi JJ
    Chem Biol; 2015 Mar; 22(3):379-90. PubMed ID: 25754473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.
    Neff CP; Zhou J; Remling L; Kuruvilla J; Zhang J; Li H; Smith DD; Swiderski P; Rossi JJ; Akkina R
    Sci Transl Med; 2011 Jan; 3(66):66ra6. PubMed ID: 21248316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
    Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
    Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals.
    Joshi PJ; Fisher TS; Prasad VR
    Curr Drug Targets Infect Disord; 2003 Dec; 3(4):383-400. PubMed ID: 14754437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.
    Pang KM; Castanotto D; Li H; Scherer L; Rossi JJ
    Nucleic Acids Res; 2018 Jan; 46(1):e6. PubMed ID: 29077949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the therapeutic applications of siRNAs against HIV-1.
    Martínez MA
    Methods Mol Biol; 2009; 487():343-68. PubMed ID: 19301656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-siRNA chimeras for HIV.
    Takahashi M; Burnett JC; Rossi JJ
    Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current progress in the development of RNAi-based therapeutics for HIV-1.
    Zhou J; Rossi JJ
    Gene Ther; 2011 Dec; 18(12):1134-8. PubMed ID: 21956690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.
    Zhou J; Neff CP; Swiderski P; Li H; Smith DD; Aboellail T; Remling-Mulder L; Akkina R; Rossi JJ
    Mol Ther; 2013 Jan; 21(1):192-200. PubMed ID: 23164935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed HIV-1 evolution of protease inhibitor resistance by second-generation short hairpin RNAs.
    Schopman NC; Braun A; Berkhout B
    Antimicrob Agents Chemother; 2012 Jan; 56(1):479-86. PubMed ID: 22064528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
    Zhou J; Li H; Li S; Zaia J; Rossi JJ
    Mol Ther; 2008 Aug; 16(8):1481-9. PubMed ID: 18461053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of drug-resistant HIV-1 by RNA interference.
    Huelsmann PM; Rauch P; Allers K; John MJ; Metzner KJ
    Antiviral Res; 2006 Jan; 69(1):1-8. PubMed ID: 16290277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Selection of Gp120 ssDNA Aptamer to HIV-1.
    Sepehri Zarandi H; Behbahani M; Mohabatkar H
    SLAS Discov; 2020 Oct; 25(9):1087-1093. PubMed ID: 32452249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.